Reuters logo
2 months ago
BRIEF-Merck provides update on reveal outcomes study of Anacetrapib
June 27, 2017 / 11:27 AM / 2 months ago

BRIEF-Merck provides update on reveal outcomes study of Anacetrapib

June 27 (Reuters) - Merck & Co Inc

* Merck provides update on reveal outcomes study of Anacetrapib

* Merck provides update on reveal outcomes study of Anacetrapib

* Reveal outcomes study of anacetrapib met its primary endpoint

* Study of anacetrapib met its primary endpoint

* Plans to review results of trial with external experts, will consider whether to file new drug applications with U.S. FDA

* Safety profile of Anacetrapib in early analysis was generally consistent with that demonstrated in previous studies of drug

* Reveal study significantly reduced major coronary events versus placebo in patients at risk for cardiac events already getting LDL-C lowering regimen Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below